Welcome to the Science Summit at the United Nations General Assembly (UNGA77)
Please Register by clicking HERE
Registration is free of charge. You can register yourself and also other colleagues (up to 10 people).
After you have registered, you will receive two emails: one from Eventbrite with your ticket, and 15 min later, one from SCHED inviting you to create your username and password (these will be your SCHED login details to access the conference each time).
Once you have your SCHED login details, you can select the session(s) you would like to attend and be able to see the ZOOM link to join your selected sessions.
All times in the AGENDA are New York Local (Eastern Daylight Time (EDT)). To view times in another time zone, please use the "Timezone" box located below on the right.
You have 2 tickets. Adding sessions to your schedule will reserve 2 seats.
Let your friends create their own schedule by transferring your tickets on Eventbrite.
View the how-to guide.
General Admission + General Admission
Back To ScheduleLet your friends create their own schedule by transferring your tickets on Eventbrite.
View the how-to guide.
General Admission + General Admission
Thursday, September 22 • 12:30pm - 2:30pm
(REF 22116) Artificial Intelligence Research in Health: Tackling Global Challenges as One - Convened by The International Digital Health & AI Research Collaborative (I-DAIR), Switzerland [ONLINE]
Click here to add to My Schedule.
Click here to add to My Schedule.[ONLINE] Artificial Intelligence Research in Health: Tackling Global Challenges as One - Convened by The International Digital Health & AI Research Collaborative (I-DAIR), Switzerland
N.B. This session is for online attendance only. Should you wish to register for the in-person session please register here.
Artificial Intelligence (AI) can help unlock new preventive treatments, advance personalized medicine, and implement precise public health interventions. However, there is a growing knowledge power imbalance between a few countries leading in AI and the rest of the world. In particular, researchers and innovators in low-middle income countries (LMICs) lack the required training, high-quality datasets, and infrastructure to develop and apply algorithms based on their own contexts. Furthermore, initiatives to build health datasets are often siloed, thereby limiting their value for the AI research and development (R&D) landscape due to a lack of scale and diversity. These challenges make it difficult to conduct inclusive and impactful AI research in health that provides global benefits.
In order to harness the power of AI in health, I-DAIR and its partners believe in a transdisciplinary, collaborative approach to AI research in health, with a focus on bringing together the voices of different LMICs stakeholders from the outset. Having a neutral, trusted space for knowledge exchange and where existing technologies are available as digital public goods can enable the global R&D agenda to manifest sustainably and bring us closer to achieving Sustainable Development Goal (SDG) 3.
The International Digital Health & AI Research Collaborative (I-DAIR) and its global partners from the United Nations University Institute in Macau (UNU Macau), Indraprastha Institute of Information Technology Delhi (IIIT-Delhi), Universidade Federal do Rio Grande do Sul (UFRGS), the Africa-Canada AI and & Data Innovation Consortium (ACADIC) led by York University and the University of the Witwatersrand, and the City University of New York (CUNY) are thus conducting a session to explore how collaborative research in AI for health can be established and sustained, as well as how technology can help to overcome pressing global health challenges advancing healthy lives and well-being for all.
Divided into two discussions, this session will introduce practical and applicable solutions in response to the recommendations made by the UN Secretary-General’s High-level Panel on Digital Cooperation, focusing on health challenges as a use case to help identify potential action points and catalyze international collaboration to address them.
The first panel “Promoting collaborative research in AI for health” will look at promoting collaborative research for responsible AI for health by means of levelling the playing field and promoting inclusivity and transdisciplinarity in research to foster responsible development and deployment of AI in health with contextualized and unbiased technology that can ensure human agency over AI in the long run.
The second panel “State of the art in AI for health” will explore how to leverage technology to overcome pressing global health challenges (namely anti-microbial resistance, outbreaks of emerging infectious diseases, cardiovascular diseases, and environmental changes) and provide effective methods of early detection. Going beyond the traditional vertical approach, we will explore how AI can help cut across scientific silos to promote a holistic approach to solving these challenges.
This event will contribute to advancing national and international R&D agendas and digital health strategies by bringing examples and evidence from different contexts on the use of technology for achieving SDG 3. It will enrich and deepen the dialogue between government representatives, scientists and civil society on some of the most pressing challenges and opportunities in using AI to improve the future of healthcare and drive universal health coverage.
The draft program of this virtual event is as follows:
12:30pm (EST)
Opening Remarks
Keynote Speech
Panel 1 - Promoting collaborative research in AI for health
1:35pm
Panel 2 - State of the art in AI for health
Closing remarks
N.B. This session is for online attendance only. Should you wish to register for the in-person session please register here.
Artificial Intelligence (AI) can help unlock new preventive treatments, advance personalized medicine, and implement precise public health interventions. However, there is a growing knowledge power imbalance between a few countries leading in AI and the rest of the world. In particular, researchers and innovators in low-middle income countries (LMICs) lack the required training, high-quality datasets, and infrastructure to develop and apply algorithms based on their own contexts. Furthermore, initiatives to build health datasets are often siloed, thereby limiting their value for the AI research and development (R&D) landscape due to a lack of scale and diversity. These challenges make it difficult to conduct inclusive and impactful AI research in health that provides global benefits.
In order to harness the power of AI in health, I-DAIR and its partners believe in a transdisciplinary, collaborative approach to AI research in health, with a focus on bringing together the voices of different LMICs stakeholders from the outset. Having a neutral, trusted space for knowledge exchange and where existing technologies are available as digital public goods can enable the global R&D agenda to manifest sustainably and bring us closer to achieving Sustainable Development Goal (SDG) 3.
The International Digital Health & AI Research Collaborative (I-DAIR) and its global partners from the United Nations University Institute in Macau (UNU Macau), Indraprastha Institute of Information Technology Delhi (IIIT-Delhi), Universidade Federal do Rio Grande do Sul (UFRGS), the Africa-Canada AI and & Data Innovation Consortium (ACADIC) led by York University and the University of the Witwatersrand, and the City University of New York (CUNY) are thus conducting a session to explore how collaborative research in AI for health can be established and sustained, as well as how technology can help to overcome pressing global health challenges advancing healthy lives and well-being for all.
Divided into two discussions, this session will introduce practical and applicable solutions in response to the recommendations made by the UN Secretary-General’s High-level Panel on Digital Cooperation, focusing on health challenges as a use case to help identify potential action points and catalyze international collaboration to address them.
The first panel “Promoting collaborative research in AI for health” will look at promoting collaborative research for responsible AI for health by means of levelling the playing field and promoting inclusivity and transdisciplinarity in research to foster responsible development and deployment of AI in health with contextualized and unbiased technology that can ensure human agency over AI in the long run.
The second panel “State of the art in AI for health” will explore how to leverage technology to overcome pressing global health challenges (namely anti-microbial resistance, outbreaks of emerging infectious diseases, cardiovascular diseases, and environmental changes) and provide effective methods of early detection. Going beyond the traditional vertical approach, we will explore how AI can help cut across scientific silos to promote a holistic approach to solving these challenges.
This event will contribute to advancing national and international R&D agendas and digital health strategies by bringing examples and evidence from different contexts on the use of technology for achieving SDG 3. It will enrich and deepen the dialogue between government representatives, scientists and civil society on some of the most pressing challenges and opportunities in using AI to improve the future of healthcare and drive universal health coverage.
The draft program of this virtual event is as follows:
12:30pm (EST)
Opening Remarks
- Dr. Christoph Benn – Chair, I-DAIR Board (Switzerland)
Keynote Speech
- USG Amandeep Singh Gill – Secretary-General’s Envoy on Technology (United Nations)
Panel 1 - Promoting collaborative research in AI for health
- Prof. Anurag Agrawal – Dean, Biosciences and Health Research, Trivedi School of Biosciences, Ashoka University (India)
- Dr. Dominique Charron – Vice-President, Programs and Partnerships, IDRC (Canada)
- Dr. Sathy Rajasekharan – Co-Executive Director, Jacaranda Health (Kenya)
- Dr. Soumya Swaminathan – Chief Scientist, WHO (Switzerland)
- CERN representative TBC (Switzerland)
- [moderator] Dr. Christoph Benn – Chair, I-DAIR Board (Switzerland)
1:35pm
Panel 2 - State of the art in AI for health
- Mr. Jake Okechukwu Effoduh – Chief Counsel, ACADIC (Canada/Nigeria)
- Prof. Bruce Y. Lee – Executive Director, Center for Advanced Technology and Communication in Health (CATCH), CUNY School of Public Health representative (USA)
- Prof. Bruce Mellado – University of the Witwatersrand/iThemba LABS (South Africa)
- Prof. Carisi Polanczyk – Professor of Medicine, UFRGS (Brazil)
- Dr. Serge Stinckwich – Head of Research, UNU-Macau (United Nations)
- [moderator] Dr. Peiling Yap – Chief Scientist, I-DAIR (Switzerland/Malaysia)
Closing remarks
- Dr. Stefan Germann – CEO, Fondation Botnar (Switzerland)
Moderator
Speakers
Conveners
Dr. Christoph Benn
Chair of the Board, IDAIR
Dr. Benn is the Director of Global Health Diplomacy at the Joep Lange Institute and Chair of I-DAIR’s Inaugural Board. Medical doctor with 30+ years of experience in global public health, he worked formerly with the Global Fund as Director of External Relations.
Dr. Peiling Yap
I-DAIR, Switzerland/Malaysia, Chief Scientist
Swiss epidemiologist, born and raised in Malaysia and Singapore, Dr. Yap is I-DAIR's Chief Scientist, where she is currently co-leading the research portfolio. She is, in particular, working with I-DAIR’s partners across the world on research topics such as pandemic preparedness... Read More →
Speakers
USG Amandeep Singh Gill
Under Secretary-General, Tech Envoy, United Nations
USG Gill is the UN Secretary-General's Envoy on Technology and former I-DAIR CEO and Project Director. Previously, he was the Executive Director and Co-Lead of the United Nations Secretary-General’s High-Level Panel on Digital Cooperation (2018-2019). In addition to delivering the... Read More →
Prof. Anurag Agrawal
Trivedi School of Biosciences, Ashoka University (India, Dean, Biosciences and Health Research
Professor Anurag Agrawal is Dean, BioSciences and Health Research, Trivedi School of Biosciences, Ashoka University, India, and former director of the Institute of Genomics and Integrative Biology, a national laboratory of CSIR, India. His primary research is in respiratory biology... Read More →
Dr. Dominique Charron
Vice-President, Programs and Partnerships, International Development Research Centre (IDRC)
Prior to her role as vice-president of the IDRC, Dominique was the director of IDRC’s Agriculture and Environment program. She supervised research focused on increasing agricultural productivity and food security, reducing vulnerability to climate change, and protecting the public... Read More →
Sathy Rajasekharan
Co-Executive Director, Jacaranda Health
Dr. Sathy Rajasekharan is the Executive Director (Africa) at Jacaranda Health, and oversees the organization's mission of delivering low-cost, sustainable solutions through public hospitals to improve maternal and newborn health outcomes. Prior to joining Jacaranda Health, Sathy was... Read More →
Dr Soumya Swaminathan
Chief Scientist, World Health Organization (WHO)
Dr Soumya Swaminathan is Chief Scientist at the World Health Organization (WHO). She previous served as WHO's Deputy Director-General for Programmes. A paediatrician from India and a globally recognized researcher on tuberculosis and HIV, she brings with her 30 years of experience... Read More →
Mr. Jake Okechukwu Effoduh
Chief Counsel, ACADIC, Canada/Nigeria
An experienced lawyer with expertise in human rights, tech, and artificial intelligence.Demonstrated history of working across various national, regional, and international institutions.I hold two masters degrees in international law and an extensive portfolio of credentials from... Read More →
Prof. Bruce Y. Lee
Executive Director, Center for Advanced Technology and Communication in Health (CATCH), City University of New York (CUNY) School of Public Health
Prof. Bruce Mellado
Co-President, ACADIC, University of the Witwatersrand and iThemba LABS
Prof. Bruce Mellado is Professor at Wits University and a Senior Scientist at iThemba LABS of the NRF and serves as the Director of the Institute for Collider Particle Physics. He is also the National Contact Physicist of South Africa at the ATLAS experiment at CERN and is the co-Chair... Read More →
Prof. Carisi Polanczyk
Professor of Medicine,, UFRGS, Brazil
Dr. Polanczyk is a cardiologist, Professor of Medicine and Coordinator of the National Institute for Health Technology Assessment/CNPq in Brazil. She is the Chief of Cardiology at Hospital Moinhos de Vento, and ahead of Heart Failure Standard Set implementation since 2017. Her clinical... Read More →
Dr. Serge Stinckwich
Head of Research, UNU-Macau
Serge is a computer scientist and the Head of Research at the United Nations University Institute in Macau. Before joining UNU, he was an Associate Professor at the University of Caen Normandie (France) and a researcher in the UMMISCO international joint research unit of IRD (French... Read More →
Dr. Stefan Germann
CEO, Fondation Botnar, Switzerland
Stefan Germann is the CEO of Fondation Botnar. Fondation Botnar is a Swiss-based foundation which champions the use of AI and digital technology to improve the health and wellbeing of children and young people in growing urban environments. To achieve this, the foundation supports... Read More →
Conveners
Dr. Brian Li Han Wong
Scientific Community Manager, The International Digital Health & AI Research Collaborative (I-DAIR)
Born in Malaysia and raised in Canada, Brian is public health specialist and multidisciplinary researcher interested in digital health, global health governance, immunisation/vaccination policy, and youth engagement.Brian’s long-standing passion for meaningful youth engagement in... Read More →
Thursday September 22, 2022 12:30pm - 2:30pm EDT
Online
Online
Feedback form isn't open yet.
This eWallet restriction is 점보카지노 even discovered on a number of the} best on line casino provides. If you disregard any of those special phrases, you danger shedding all of your bonus winnings. Players wants to|must also} play close attention to ant restrictions on how you can wager.
ReplyDelete